Arix Bioscience PLC (ARIX) Unaudited NAV for December 2022 30-Jan-2023 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

Arix Bioscience plc

Unaudited NAV for December 2022

LONDON, 30 January 2023: Arix Bioscience plc ("Arix" or the "Company") (LSE: ARIX), a global venture capital company focused on investing in breakthrough biotechnology companies, announces the unaudited Net Asset Value ("NAV") of the Company for the date ended 31 December 2022 as follows:

                 NAV Breakdown 
Date                                                                         Total NAV 
                 Listed Portfolio Unlisted Portfolio Cash    Other Interests           NAV per share 
31 December 2022 
                 GBP47.0m           GBP56.2m             GBP123.4m GBP3.0m           GBP229.6m   GBP1.78 
(unaudited)

[ENDS]

Enquiries

For more information on Arix, please contact:

Arix Bioscience plc

+44 (0)20 7290 1050

ir@arixbioscience.com

Powerscourt Group

Sarah MacLeod, Ibrahim Khalil, Nick Johnson

+44 (0)20 7250 1446

arix@powerscourt-group.com

About Arix Bioscience plc

Arix Bioscience plc is a global venture capital company focused on investing in breakthrough biotechnology companies around cutting-edge advances in life sciences.

We collaborate with exceptional entrepreneurs and provide the capital, expertise, and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors. www.arixbioscience.com

-----------------------------------------------------------------------------------------------------------------------

ISIN:           GB00BD045071 
Category Code:  NAV 
TIDM:           ARIX 
LEI Code:       213800OVT3AHQCXNIX43 
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State 
Sequence No.:   219090 
EQS News ID:    1545893 
 
End of Announcement  EQS News Service 
=------------------------------------------------------------------------------------

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1545893&application_name=news

(END) Dow Jones Newswires

January 30, 2023 02:00 ET (07:00 GMT)

Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Arix Bioscience Charts.
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Arix Bioscience Charts.